PHG
Koninklijke Philips
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 2
Sell signal 1
consensus rating "Strong Buy"
Revenue Beats Expectation
EPS Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About PHG
Koninklijke Philips N.V.
A leading health technology company that focused on healthy living and prevention, diagnosis, treatment, and home care
Healthcare Providers and Services
Invalid Date
04/14/1987
New York Stock Exchange
66678
12-31
Common stock
Philips Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands
Health care services such as diagnosis and treatment
Koninklijke Philips N.V. was incorporated in Eindhoven in 1891. As a leading health technology company, the company believes in innovation to improve people's health and healthcare outcomes and make care more accessible and affordable. Guided by this goal, their strategy is to lead by innovative solutions that combine systems, smart devices, informatics and services and leverage big data — helping their clients achieve four-fold goals (better health outcomes, improved patient experience, improved employee experience, lower cost of care) and helping people take better care of their own health at every stage of life.
Company Financials
EPS
PHG has released its 2023 Q4 earnings. EPS was reported at 0.44, versus the expected 0.62, missing expectations. The chart below visualizes how PHG has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
PHG has released its 2024 Q4 earnings report, with revenue of 5.22B, reflecting a YoY change of -6.76%, and net profit of -344.69M, showing a YoY change of -919.99%. The Sankey diagram below clearly presents PHG’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
